Active Clinical Trials
Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.
- Sort by Sort ascending
- Study title
- Condition
- Phase
- Location
- NCT ID
| Study title | Condition | Phase | Location | NCT ID |
|---|---|---|---|---|
Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN |
IC-MPGN | Phase3 | Argentina Brazil Canada Czechia Denmark France Germany Greece India Israel Italy Japan Netherlands Poland Slovakia South Korea Spain Switzerland Taiwan Turkey (Türkiye) United Kingdom United States Vietnam View all |
NCT05755386 |
Efficacy and Safety of Switching From Anti-C5 Antibody Treatment to Iptacopan Treatment in Study Participants With Atypical Hemolytic Uremic Syndrome (aHUS) |
Atypical Hemolytic Uremic Syndrome | Phase3 | France Germany Italy Japan Spain Turkey (Türkiye) United Kingdom View all |
NCT05935215 |
Alpelisib in Pediatric and Adult Patients With Lymphatic Malformations Associated With a PIK3CA Mutation. |
Lymphatic Malformations | Phase2, Phase3 | Argentina Australia Belgium France Germany Italy Netherlands Spain Switzerland United States View all |
NCT05948943 |
Study to Determine the Dose and Safety of Asciminib in Pediatric Patients With Chronic Myeloid Leukemia |
Myeloid Leukemia, Philadelphia Positive | Phase1, Phase2 | China France Germany Greece Hungary Italy Japan Netherlands Poland Russia South Korea Thailand Turkey (Türkiye) United States View all |
NCT04925479 |
Ofatumumab in Portuguese Multiple Sclerosis Patients - an Observational Study |
Relapsing Multiple Sclerosis | Portugal | NCT05809986 | |
A Long-term Safety Study in Brazilian Patients With a Diagnosis of Spinal Muscular Atrophy Treated With Zolgensma |
Spinal Muscular Atrophies | Brazil | NCT06019637 | |
Study of Out of Specification for Tisagenlecleucel |
B-cell Acute Lymphoblastic Leukemia, Diffuse Large B-cell Lymphoma | Phase3 | Japan | NCT04094311 |
Kesimpta Pregnancy and Infant Safety Study Using Real World Data |
Multiple Sclerosis | Switzerland | NCT06156683 | |
Post-Authorization Safety Study for Assessment of Pregnancy Outcomes in Patients Treated With Mayzent |
Multiple Sclerosis | United States | NCT04933552 | |
Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN |
C3 Glomerulopathy, Immune-complex-membranoproliferative Glomerulonephritis | Phase3 | Argentina Brazil China France Germany Greece Israel Italy Japan Netherlands Spain Switzerland Turkey (Türkiye) United Kingdom United States View all |
NCT03955445 |